Phase 1 Randomized Trial of the Vaginal Safety and Acceptability of SPL7013 Gel (VivaGel) in Sexually Active Young Women (MTN-004)
AIDS - United States
doi 10.1097/qad.0b013e328346bd3e
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)